Skip to content
2000
Volume 8, Issue 1
  • ISSN: 1872-2148
  • E-ISSN: 2212-3334

Abstract

Dendritic cell (DC) immunotherapy has been used to treat various types of tumors. Although it is already in use in clinical practice, the mechanisms through which it acts need clarification. In addition, the processes used to obtain DCs need to be improved so that more effective treatments can be offered. In this article, we present an update on the application of DC immunotherapy and the patents involved in the process.

Loading

Article metrics loading...

/content/journals/emi/10.2174/1872214807666140107152008
2014-01-01
2025-09-03
Loading full text...

Full text loading...

/content/journals/emi/10.2174/1872214807666140107152008
Loading

  • Article Type:
    Research Article
Keyword(s): Cancer; dendritic cells; immunotherapy; neoplasia; new aspects; patents in immunotherapy; tumor
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test